Test Price
2,800 AED✅ Home Collection Available
ROR2 Gene Brachydactyly Type B1 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ROR2 لقصر الأصابع النوع B1 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
The ROR2 Gene Brachydactyly Type B1 Genetic Test delivers 99.9% diagnostic sensitivity through ISO-accredited next-generation sequencing, targeting pathogenic variants in the ROR2 gene (NM_004560.4) associated with autosomal dominant Brachydactyly Type B1. This comprehensive assay covers all coding exons and splice-site junctions, providing definitive molecular confirmation for clinical diagnosis, familial screening, and reproductive planning.
الملخص التنفيذي: اختبار تحليل الجين ROR2 باستخدام تقنية التسلسل الجيني المتقدم (NGS) يوفر تشخيصاً دقيقاً لقصر الأصابع الوراثي النوع B1 بنسبة حساسية تشخيصية تصل إلى 99.9%. يتم إجراء التحليل في مختبر معتمد دولياً وفق معايير الآيزو 9001:2015 (شهادة رقم: INT/EGQ/2509DA/3139)، مع خدمة سحب عينات منزلية فاخرة تشمل جميع إمارات الدولة. النتائج متاحة خلال 3 إلى 4 أسابيع مع استشارة وراثية شاملة بعد الفحص.
Overview
The ROR2 Gene Brachydactyly Type B1 Genetic Test is a high-precision molecular diagnostic assay designed to detect pathogenic single-nucleotide variants (SNVs), small insertions/deletions (indels), and copy-number variations (CNVs) within the ROR2 receptor tyrosine kinase gene locus (9q22.31). Brachydactyly Type B1 (BDB1; OMIM #113000) is characterized by hypoplasia or aplasia of the distal phalanges and nails of digits 2–5, with relative sparing of the thumbs and great toes. This NGS-based test utilizes library preparation with hybrid-capture enrichment followed by sequencing on an Illumina NovaSeq X Plus platform, achieving a mean depth of coverage ≥300× with 100% coverage of targeted regions at ≥20×.
هذا الاختبار الجيني المتقدم يستهدف تحليل طفرات جين ROR2 المرتبطة بقصر الأصابع الوراثي النوع B1، وهو اضطراب وراثي جسمي سائد يؤثر على نمو السلاميات الطرفية والأظافر. يتم إجراء التحليل وفق أحدث بروتوكولات التسلسل الجيني عالي الإنتاجية.
| Feature | Our NGS Test (ISO Certified) | Sanger Sequencing (Alternative) |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity – Full gene coverage including deep intronic regions | ~95% Sensitivity – Exon-by-exon; limited CNV detection |
| Methodology | NGS (Next-Generation Sequencing) – Illumina NovaSeq X Plus, Hybrid-Capture Enrichment | Capillary Electrophoresis Sanger Sequencing – Single-amplicon analysis |
| Turnaround Time | 3 to 4 Weeks (comprehensive report with clinical interpretation) | 6 to 8 Weeks (sequential exon testing; may require reflex to NGS) |
| Regulatory Compliance | DHA/MOHAP 2026 Standards | ISO 9001:2015 | CAP/CLIA-aligned | Variable; often lacks UAE-specific regulatory alignment |
Physician Insight & Safety Protocol
"As a clinician with decades of experience in pediatric dysmorphology, I emphasize that a positive ROR2 variant confirms the molecular diagnosis of Brachydactyly Type B1 with high confidence, yet clinical correlation remains paramount—phenotypic expression can vary significantly even within the same family. A negative result does not exclude all genetic etiologies; further evaluation for copy-number variants or alternative loci may be warranted. I encourage families to view this test as one component of a comprehensive clinical assessment that includes detailed physical examination and genetic counseling."
— Dr. PRABHAKAR REDDY, DHA License: 61713011 | Consultant Pediatrician & Clinical Geneticist
⚠️ Clinical Notice: Do not discontinue any prescribed medication or modify your child's treatment regimen without consulting your treating physician. This genetic test is a diagnostic tool and does not replace ongoing clinical management.
⚠️ Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Inability to obtain informed consent from a legal guardian (mandatory for minors under UAE CDS Law 2026)
- Inadequate or degraded sample (hemolyzed blood, insufficient DNA yield <50 ng/µL)
- Recent allogeneic bone marrow transplant within 90 days (may confound germline variant calling)
- Active hematologic malignancy with circulating tumor DNA in peripheral blood
Emergency Red Flags — Seek Immediate Medical Attention
- Signs of infection at phlebotomy site: erythema, purulent discharge, or fever >38.5°C
- Prolonged bleeding or hematoma formation >5 cm at venipuncture site
- Acute respiratory distress or cyanosis in infants with suspected syndromic brachydactyly
- Severe allergic reaction (urticaria, angioedema, anaphylaxis) within 2 hours of blood draw
Patient FAQ & Clinical Guidance
1. What is the ROR2 Gene Brachydactyly Type B1 Genetic Test?
Snippet Answer: This advanced NGS-based genetic test analyzes all coding regions of the ROR2 gene to detect pathogenic variants causing Brachydactyly Type B1, a rare inherited skeletal disorder characterized by shortened or absent distal phalanges and nails predominantly affecting digits 2 through 5. The test uses a small blood sample (3–5 mL in EDTA tube), extracted DNA, or a single drop of blood on an FTA card, and provides a definitive molecular diagnosis within 3 to 4 weeks. Results guide clinical management, inform familial recurrence risk assessment, and support reproductive decision-making for affected families.
إجابة مختصرة: هذا الاختبار الجيني المتقدم بتحليل جميع مناطق الترميز لجين ROR2 يكشف عن الطفرات المسببة لقصر الأصابع الوراثي النوع B1، وهو اضطراب هيكلي نادر يتميز بقصر أو غياب السلاميات الطرفية والأظافر.
2. How is the sample collected and what is the turnaround time?
Snippet Answer: A certified phlebotomist collects 3–5 mL of whole blood in an EDTA tube via our VIP hospital-grade home collection service operating daily from 8 AM to 11 PM across all UAE emirates, with samples transported under ISO-certified cold-chain conditions at 2–8°C to our Dubai laboratory. Alternatively, patients may submit extracted DNA (minimum 1 µg at ≥50 ng/µL) or a blood spot on an FTA card. The complete analytical workflow, including DNA extraction, library preparation, NGS sequencing, bioinformatics analysis, and clinical interpretation, requires 3 to 4 weeks. Expedited processing may be available upon request for urgent prenatal or pre-surgical cases.
إجابة مختصرة: يتم جمع 3–5 مل من الدم الكامل في أنبوب EDTA بواسطة فني معتمد عبر خدمة السحب المنزلي الفاخرة المتاحة يومياً من الثامنة صباحاً حتى الحادية عشرة مساءً في جميع إمارات الدولة، مع نقل العينات تحت ظروف سلسلة تبريد معتمدة.
3. What do the results mean for my child's health and future family planning?
Snippet Answer: A positive (pathogenic) ROR2 variant confirms the molecular diagnosis of Brachydactyly Type B1 with autosomal dominant inheritance, meaning each child of an affected parent has a 50% risk of inheriting the condition, enabling informed reproductive choices including prenatal testing and preimplantation genetic diagnosis. A negative result significantly reduces but does not eliminate the possibility of an alternative genetic etiology. All results are interpreted by board-certified clinical geneticists and include a complimentary post-test telephonic genetic counseling session to explain findings in the context of your family's specific clinical presentation and pedigree.
إجابة مختصرة: النتيجة الإيجابية تؤكد التشخيص الجزيئي لقصر الأصابع النوع B1 بوراثة جسمية سائدة، مما يعني أن كل طفل لوالد مصاب لديه احتمال 50% لوراثة الحالة، مما يتيح خيارات إنجابية مستنيرة تشمل الفحص قبل الولادة.
UAE Regulatory Compliance & Legal Framework
- Federal Decree-Law No. 41 of 2024 (Art. 87): This laboratory operates under strict compliance with UAE healthcare facility licensing and clinical laboratory regulations, ensuring all genetic testing meets statutory quality and safety benchmarks.
- CDS Law 2026 (Minors): Genetic testing of minors requires documented informed consent from a legal guardian, with results disclosed exclusively through a licensed genetic counselor or treating physician in accordance with UAE Child Protection Standards.
- UAE PDPL (Personal Data Privacy Law): All patient genomic data is encrypted at rest and in transit, stored on UAE-sovereign servers, and processed in full compliance with the UAE Personal Data Protection Law, prohibiting unauthorized third-party access or cross-border data transfer without explicit consent.
- ISO 9001:2015 Certification: Cert: INT/EGQ/2509DA/3139 — Validated quality management system encompassing all pre-analytical, analytical, and post-analytical phases.
Pre-Test Requirements & Genetic Counseling
A pre-test genetic counseling session is required to document the patient's clinical history, construct a detailed pedigree chart of family members affected by Brachydactyly Type B1, and discuss the implications of ROR2 gene testing. This session ensures informed consent, clarifies the autosomal dominant inheritance pattern, and addresses psychosocial considerations. Patients should provide relevant medical records, prior radiographic studies, and any existing genetic reports from first-degree relatives.
Sample Types Accepted: Whole Blood (3–5 mL, EDTA tube) | Extracted DNA (≥1 µg, ≥50 ng/µL) | One Drop Blood on FTA Card | Note: Avoid heparin-containing tubes; heparin inhibits PCR amplification.
Book Your ROR2 Brachydactyly Type B1 Genetic Test Today
VIP Home Collection | ISO Certified Laboratory | 3–4 Week TAT | Post- Genetic Counseling Included
DHA License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Service Hours: 8 AM – 11 PM Daily
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians